Stocks and Investing Stocks and Investing
Mon, February 26, 2018
Fri, February 23, 2018

Joseph Schwartz Maintained (BMRN) at Buy with Decreased Target to $132 on, Feb 23rd, 2018


Published on 2024-10-26 03:17:34 - WOPRAI, Joseph Schwartz
  Print publication without navigation


Joseph Schwartz of Leerink Swann, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Buy with Decreased Target from $142 to $132 on, Feb 23rd, 2018.

Joseph has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Joseph


  • Cory Kasimov of "JP Morgan" Maintained at Buy with Decreased Target to $129 on, Wednesday, January 24th, 2018
  • Liana Moussatos of "Wedbush" Upgraded from Hold to Buy on, Thursday, December 14th, 2017
Contributing Sources